Cytomx therapeutics, inc. (CTMX)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Sep'14
Revenues

49,593

8,279

10,712

9,013

29,485

11,471

12,509

21,338

14,184

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues

-

-

-

-

-

-

-

-

-

-

-

-

11,176

-

2,829

2,539

1,783

1,518

1,471

1,557

1,395

-

Revenues from related parties

-

-

-

-

-

-

-

-

-

-

482

469

477

578

625

555

440

470

468

486

347

-

Total revenues

-

-

-

-

-

-

-

-

-

-

24,144

8,752

11,653

6,272

3,454

3,094

2,223

1,988

1,939

2,043

1,742

1,915

Operating expenses:
Research and development

42,814

36,441

27,967

30,835

36,376

28,306

27,549

25,553

22,458

20,705

28,920

28,076

14,576

15,348

13,337

12,705

13,365

9,503

9,157

5,033

4,664

3,916

General and administrative

9,572

9,217

8,463

9,411

9,674

8,975

8,137

9,042

7,356

7,616

6,249

6,049

5,691

5,154

5,033

4,647

5,040

4,009

4,051

2,552

1,946

1,463

Total operating expenses

52,386

45,658

36,430

40,246

46,050

37,281

35,686

34,595

29,814

28,321

35,169

34,125

20,267

20,502

18,370

17,352

18,405

13,512

13,208

7,585

6,610

5,379

Loss from operations

-2,793

-37,379

-25,718

-31,233

-16,565

-25,810

-23,177

-13,257

-15,630

-1,247

-11,025

-25,373

-8,614

-14,230

-14,916

-14,258

-16,182

-11,524

-11,269

-5,542

-4,868

-3,464

Interest income

1,075

1,511

1,997

2,361

2,496

2,507

2,219

1,540

1,375

1,275

806

357

236

-159

210

195

490

441

407

329

138

2

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

353

376

718

408

230

117

Other income (expense)

12

-8

22

-88

-61

-18

29

61

-140

74

-47

-174

120

-23

45

-110

19

-26

-287

-180

-1,251

-10

Loss before income taxes

-1,706

-35,876

-23,699

-28,960

-14,130

-23,321

-20,929

-11,656

-14,395

102

-10,266

-25,190

-8,258

-14,059

-14,661

-14,173

-16,026

-11,485

-11,867

-5,801

-6,211

-3,589

Benefit from income taxes

-13,900

-421

0

0

-6

8,905

2,500

1,800

1,098

-519

-19

26

-1

-26

1

3

3

-

3

5

-

-

Net income (loss)

12,205

-35,455

-23,699

-28,960

-14,124

-32,233

-23,431

-13,447

-15,493

621

-10,247

-25,216

-8,257

-14,033

-14,662

-14,176

-16,029

-11,487

-11,870

-5,806

-6,211

-3,589

Net income (loss) per share
Basic

0.27

-

-

-

-0.31

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted

0.26

-

-

-

-0.31

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Shares used to compute net income (loss) per share
Basic

45,723

-

-

-

45,122

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted

47,044

-

-

-

45,122

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion to redemption value and cumulative dividends on preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

558

2,958

1,757

1,432

1,169

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-12,045

-14,828

-7,563

-7,643

-4,758

Net loss per share, basic and diluted

-

-

-0.52

-0.64

-

-0.75

-0.53

-0.35

-0.40

0.04

-0.28

-0.69

-0.23

-0.40

-0.40

-0.39

-0.44

24.59

-14.26

-7.56

-7.67

-4.86

Shares used to compute net loss per share, basic and diluted

-

-

45,418

45,340

-

45,131

43,917

38,961

38,647

38,400

36,947

36,780

36,538

36,437

36,324

36,113

36,063

31,343

1,039

1,001

996

979

Other comprehensive income:
Unrealized gain on short-term investments, net of tax

279

-53

-99

136

155

115

-30

50

-134

-33

49

-10

-73

-35

-72

50

106

-68

-7

9

-10

-

Impact of adoption of new accounting pronouncement

-

-

-

-

11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other comprehensive (loss) / income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-72

50

106

-

-7

9

-10

-

Comprehensive income (loss)

12,484

-35,508

-23,798

-28,824

-13,958

-32,118

-23,461

-13,397

-15,627

588

-10,198

-25,226

-8,330

-14,068

-14,734

-14,126

-15,923

-11,555

-11,877

-5,797

-6,221

-3,589